Identify and narrow the universe of dose values |
Retrospective analysis of data from completed RCT(s) |
Provides quantitative evaluation of dose–response relationship
Permits identification of cases for post hoc analyses (e.g., qualitative interviews of participants who were not adherent to the protocol) to inform future studies
Comparison of intended and actual dose can be informative
Permits evaluation of moderators of dose–response relationship via meta-regression
|
No randomization
Reverse causation: positive dose–response relationship may indicate that participants improved because they received more intervention OR that they participated more because they improved
Heterogeneity in control groups and interventions can obscure inferences
|
Assessment of perceived optimal intervention dose via prospective survey or interview of key stakeholders |
Involves multiple stakeholders, including patients, providers, operations partners, and administrators
Evaluates perceived feasibility, acceptability, efficacy, or effectiveness of proposed doses
Includes open- or close-ended questions
Assesses broad range of issues efficiently
|
|
Assessment of target patient behavior via prospective, longitudinal, observational studies |
Determine how frequently unwanted thoughts, feelings, and behaviors occur (e.g., missed medication doses)
Examine long-term change or short-term variability in behaviors
|
No randomization
Selection bias
Attrition
Time burden
|
Validate expectation of optimal dose |
Early-phase nonrandomized methods |
Small sample size
Strong alternative when randomization is not feasible
Adaptive
Precise and provides confidence intervals around optimal dose
Considers both minimally effective dose and maximally tolerated dose
|
|
Randomized designs |
Maximizes internal validity
Examines interactions between dose parameters or dose parameters and other intervention components
If more than one dose is efficacious, can distinguish optimal dose based on resources required
Can evaluate sequences of dosing schedules
|
|